I am currently completing a PhD in the Leeds Institute of Health Sciences. My thesis is entitled 'investigating decision-making in cancer preventive therapy'.
I graduated from the University of Manchester in 2015 with a BSc (Hons) in Psychology. I first became passionate about cancer prevention research when I worked as a project assistant in the Manchester BRC (NIHR) theme Cancer Prevention and Early Detection Research at the The Christie NHS Foundation Trust (2015-2018). In 2018, I was awarded an Economic and Social Research Council funded 1+3 PhD focusing on the area of cancer preventive therapy and behavioural science, and in 2019 I obtained an ESRC-funded MA in Social Research (Interdisciplinary) from the University of Leeds.
Throughout my PhD I have undertaken / currently undertaking several mixed methods research studies, such as:
- Systematic review of the literature synthesising evidence on behaviour and attitudes data in the context of aspirin for cancer preventive therapy.
- Qualitative studies exploring user and healthcare providers' views on the use of aspirin for colorectal cancer prevention.
- Factorial randomised trial recruiting general practitioners (GPs).
The majority of my PhD has investigated informed decision-making in the context of the recent NICE guidance (NG151) recommending aspirin for colorectal cancer prevention for higher genetic risk populations (i.e. people with Lynch syndrome).
I am a keen advocate for open / science research practices, and the lead organiser of the ReproducibiliTea journal club at the University of Leeds.
- Preventive therapy/ chemoprevention
- The use of aspirin for preventive therapy
- Behavioural science / health psychology
- Quantitative and qualitative research methods
- Open and reproducible science/ research
- BSc Psychology, University of Manchester (2015)
- MA Social Research (Interdisciplinary), University of Leeds (2019)
Research groups and institutes
- Leeds Institute of Health Sciences